Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Andes virus envelope glycoprotein Gn is a structural glycoprotein present on the surface of Andes virus, a highly pathogenic member of the Hantavirus genus (family Hantaviridae). Gn, together with the Gc glycoprotein, forms heterodimeric and tetrameric spike complexes that constitute the virus's outer envelope lattice. The Gn glycoprotein is essential for viral assembly, cell entry (including receptor binding and trafficking), and budding. Its cytoplasmic tail mediates critical interactions with ribonucleoprotein particles necessary for viral replication and assembly[1][2][4][7][8]. Structurally, Gn is a type I transmembrane protein with a large ectodomain and a cytoplasmic tail that includes a zinc finger domain implicated in protein–protein binding[1][2]. Gn is immunogenic, representing a principal target for virus-neutralizing antibodies and a candidate for vaccine development[4][5][7]. Andes virus and its glycoproteins are the central agents in hantavirus cardiopulmonary syndrome (HCPS) in South America, for which there are no approved therapeutics; current medical research aims to exploit Gn as a therapeutic and diagnostic target[4][7][8].
Inhibiting virus–cell entry (by blocking Gn/host receptor or interfering with spike function; mainly theoretical or vaccine/antibody-based) Inhibiting glycoprotein-mediated fusion
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Andes virus envelope glycoprotein Gn (Gn).